All joking aside, a bit of commentary on internet culture. The anti-gun slight invariably masks a sexist and patriarchal chauvinism. What sort of part of the female anatomy would be considered inadequate and therefore the analytic key, to interpreting why a female would want to own and occasionally carry/shoot firearms? The anti-gun apparatchik ranks are overflowing with misogynists, albeit careful to hide their contempt. For that matter they are over-flowing with crypto-racists too, but that is for another post...
Types of molecular targeted therapy
ReplyDeleteThe reason why the molecular targeted therapy be closely watched, and cause researchers' interest, because it change the characteristics of the tumor cells as a target at the same time play a stronger anti-tumor activity, less toxic to normal cells side effects. This targeted treatment for cancer treatment indicate a new direction.
According to the target and the nature of the role of drugs, the major molecular targeted therapy drugs are divided into the following categories:
1 small molecule epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors, such as gefitinib imatinib (Gefitinib, Iressa, Iressa); erlotinib (Erlotinib, Tarceva);
(2) anti-EGFR monoclonal antibody, cetuximab (Cetuximab, Erbitux);
Anti-HER-2 monoclonal antibody, such as Herceptin (Trastuzumab Herceptin);
4.Bcr-ABL tyrosine kinase inhibitors such as imatinib (Imatinib);
Vascular endothelial growth factor receptor inhibitors, such as Bevacizumab (Avastin Avastin), Endostar;
6 anti-CD20 monoclonal antibody, rituximab (Rituximab);
7.IGFR-1 kinase inhibitors, such as NVP-AEW541;
8.mTOR kinase inhibitors, such as CCI-779;
Ubiquitin - proteasome inhibitor, bortezomib (bortezomib, Velcade);
10, such as Aurora kinase inhibitors, histone deacetylases (HDACs) inhibitors.
Medchemexpress Can provide the above product,its website:www.medchemexpress.com
Tandutinib
KW-2449
Quizartinib
AST 487
Linifanib
Canertinib
Canertinib dihydrochloride
CP-724714 (E-Double bond)
2-Methoxyestradiol
GSK1904529A